Big Pharma Split (TSX:PRM) FCF Yield % : 72.70 (As of Jun. 05, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Big Pharma Split's Trailing 12-Month Free Cash Flow is C$11.86 Mil, and Market Cap is C$16.31 Mil. Therefore, Big Pharma Split's FCF Yield % for today is 72.70%.

The historical rank and industry rank for Big Pharma Split's FCF Yield % or its related term are showing as below:

TSX:PRM' s FCF Yield % Range Over the Past 10 Years
Min: -191.26 Med: 7.16 Max: 79.74
Current: 72.7

During the past 7 years, the highest FCF Yield % of Big Pharma Split was 79.74%. The lowest was -191.26%. And the median was 7.16%.

TSX:PRM's FCF Yield % is ranked better than
97.98% of 1584 companies
in the Asset Management industry
Industry Median: 3.05 vs TSX:PRM: 72.70

Big Pharma Split's FCF Margin % for the quarter that ended in Dec. 2023 was 311.35%.

Big Pharma Split FCF Yield % Historical Data

The historical data trend for Big Pharma Split's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split FCF Yield % Chart

Big Pharma Split Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

58.37

34.71

-41.28

6.04

74.11

Big Pharma Split Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial								-18.08	1.06	10.83	118.27	16.11

Competitive Comparison of Big Pharma Split's FCF Yield %

For the Asset Management subindustry, Big Pharma Split's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Big Pharma Split's FCF Yield % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Big Pharma Split's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Big Pharma Split's FCF Yield % falls into.

Big Pharma Split FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Big Pharma Split's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	11.858	/	15.9999125
	=	74.11%

Big Pharma Split's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	1.289	*	2	/	15.9999125
	=	16.11%

Big Pharma Split FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Big Pharma Split FCF Yield % Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split (TSX:PRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

PRM.PR.A.PFD:Canada

Address

610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5

Website

https://www.harvestportfolios.com

Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Executives

Michael Kovacs

Director, Senior Officer